A detailed history of Pineridge Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Pineridge Advisors LLC holds 22 shares of ZTS stock, worth $3,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 18 22.22%
Holding current value
$3,641
Previous $3.12 Million 37.76%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$172.58 - $196.48 $690 - $785
4 Added 22.22%
22 $4.3 Million
Q1 2024

May 16, 2024

SELL
$165.67 - $199.94 $1,491 - $1,799
-9 Reduced 33.33%
18 $3.05 Million
Q4 2023

Mar 01, 2024

BUY
$151.44 - $200.09 $4,088 - $5,402
27 New
27 $5.33 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Pineridge Advisors LLC Portfolio

Follow Pineridge Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pineridge Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pineridge Advisors LLC with notifications on news.